Mark Bradley

Mark Bradley is currently serving as the Bioprocess Shift Lead at WuXi Biologics, where responsibilities include overseeing downstream operations in the manufacturing of Recombinant Protein Therapeutics since December 2020. Previously, Mark worked at Xerox for two decades, progressing from a repair technician to a Production Supervisor, where duties involved leading a team of operators and managing work scheduling to enhance efficiency and quality. Initial experience in the industry included sales and installation of submersible water pumps for Turbo Pumps Ltd. Mark holds a Certificate in People Management from QQI, a Higher Diploma in Bio-Pharmaceutical and Medical Devices from Technological University Dublin, and an Ordinary Degree in Electronics from Dundalk Institute of Technology.